Noninvasive Monitoring of Bleomycin-induced Lung Injury in Rats Using Pulmonary Function Test |
Yang, Mi-Jin
(Division of Inhalation Toxicology, KIT Jeongeup Campus)
Yang, Young-Su (Division of Inhalation Toxicology, KIT Jeongeup Campus) Kim, Yong-Bum (Division of Inhalation Toxicology, KIT Jeongeup Campus) Cho, Kyu-Hyuk (Division of Inhalation Toxicology, KIT Jeongeup Campus) Heo, Jeong-Doo (Division of Inhalation Toxicology, KIT Jeongeup Campus) Lee, Kyu-Hong (Division of Inhalation Toxicology, KIT Jeongeup Campus) Song, Chang-Woo (Division of Inhalation Toxicology, KIT Jeongeup Campus) |
1 | Antoniou, K.M., Ferdoutsis, E. and Bouros, D. (2003). Interferons and their application in the diseases of the lung. Chest, 123, 209-216 DOI ScienceOn |
2 | El-Medany, A., Hagar, H.H., Moursi, M., At Muhammed, R., El-Rakhawy, F.I. and El-Medany, G. (2005). Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur. J. Pharmacol., 509, 61-70 DOI ScienceOn |
3 | Gharaee-Kermani, M. and Phan, S.H. (2005). Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr. Pharm. Des., 11, 3943- 3971 DOI |
4 | Gharaee-Kermani, M., Ullenbruch, M. and Phan, S.H. (2005). Animal models of pulmonary fibrosis. Methods Mol. Med., 117, 251-259 |
5 | Mason, R.J., Schwarz, M.I., Hunninghake, G.W. and Musson, R.A. (1999). NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am. J. Respir. Crit. Care. Med., 160, 1771- 1777 DOI ScienceOn |
6 | Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M. (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell. Biol., 40, 362-382 DOI ScienceOn |
7 | Spond, J., Billah, M.M., Chapman, R.W., Egan, R.W., Hey, J.A., House, A., Kreutner, W. and Minnicozzi, M. (2004). The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats. Pulm. Pharmacol. Ther., 17, 133-140 DOI ScienceOn |
8 | Zhang, K., Gharaee-Kermani, M., McGarry, B. and Phan, S. H. (1994b). In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab. Invest., 70, 192-202 |
9 | Lazenby, A.J., Crouch, E.C., McDonald, J.A. and Kuhn, C. 3rd (1990). Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis., 142, 206-214 DOI ScienceOn |
10 | Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P. and Vassalli, P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature, 344, 245-247 DOI ScienceOn |
11 | Kolb, M., Margetts, P.J., Galt, T., Sime, P.J., Xing, Z., Schmidt, M. and Gauldie, J. (2001). Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am. J. Respir. Crit. Care. Med., 163, 770-777 DOI ScienceOn |
12 | Iraz, M., Erdogan, H., Kotuk, M., Yagmurca, M., Kilic, T., Ermis, H., Fadillioglu, E. and Yildirim, Z. (2006). Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol. Res., 53, 310-316 DOI ScienceOn |
13 | Nathan, S.D., Shlobin, O.A., Ahmad, S., Urbanek, S. and Barnett, S.D. (2007). Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest., 131, 657-663 DOI ScienceOn |
14 | Gross, T.J. and Hunninghake, G.W. (2001). Idiopathic pulmonary fibrosis. N. Engl. J. Med., 345, 517-525 DOI ScienceOn |
15 | Jordana, M., Dolovich, M., Irving, L.B., Tomioka, M., Befus, D., Gauldie, J. and Newhouse, M.T. (1988). Solute movement across the alveolar-capillary membrane after intratracheally administered bleomycin in rats. Am. Rev Respir. Dis., 138, 96-100 DOI ScienceOn |
16 | Karmouty-Quintana, H., Cannet, C., Zurbruegg, S., Ble, F.X., Fozard, J.R., Page, C.P. and Beckmann, N. (2007). Bleomycin- induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J. Magn. Reson. Imaging., 26, 941-949 DOI ScienceOn |
17 | Sakanashi, Y., Takeya, M., Yoshimura, T., Feng, L., Morioka, T. and Takahashi, K. (1994). Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP- 1. J. Leukoc. Biol., 56, 741-750 DOI |
18 | Yang, M.J., Kim, J.S., Yang, Y.S., Cho, J.W., Chio, S.B., Chung, Y.H., Kim, Y.B., Cho, K.H., Lim, C.W., Kim, C.Y. and Song, C.W. (2008). Pulmonary toxicity and recovery from inhalation of manual metal arc stainless steel welding fume in rats. Toxicol. Res., 24, 119-127 DOI ScienceOn |
19 | Martinez, F.J. and Flaherty, K. (2006). Pulmonary function testing in idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc., 3, 315-321 DOI ScienceOn |
20 | Ashcroft, T., Simpson, J.M. and Timbrell, V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41, 467-470 DOI |
21 | Zhang, H.Y., Gharaee-Kermani, M., Zhang, K., Karmiol, S. and Phan, S.H. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin- induced pulmonary fibrosis. Am. J. Pathol., 148, 527- 537 |
22 | Kuwano, K., Hagimoto, N. and Hara, N. (2001). Molecular mechanisms of pulmonary fibrosis and current treatment. Curr. Mol. Med., 1, 551-573 DOI |
23 | Zhang, K., Gharaee-Kermani, M., Jones, M.L., Warren, J.S. and Phan, S.H. (1994a). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol., 153, 4733-4741 |
24 | Cortijo, J., Cerda-Nicolas, M., Serrano, A., Bioque, G., Estrela, J.M., Santangelo, F., Esteras, A., Llombart-Bosch, A. and Morcillo, E.J. (2001). Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur. Respir. J., 17, 1228-1235 DOI ScienceOn |
25 | Gharaee-Kermani, M., Hu, B., Phan, S.H. and Gyetko, M.R. (2008). The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy. Expert. Opin. Investig. Drugs., 17, 905-916 DOI ScienceOn |
26 | Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K. and Iwamoto, I. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest., 104, 5-11 DOI ScienceOn |
27 | Antonini, J.M., Taylor, M.D., Millecchia, L., Bebout, A.R. and Roberts, J.R. (2004). Suppression in lung defense responses after bacterial infection in rats pretreated with different welding fumes. Toxicol. Appl. Pharmacol., 200, 206-218 DOI ScienceOn |
28 | Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W. and Breuer, R. (2002). Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol., 83, 111-119 DOI ScienceOn |
29 | Okada, T., Sugie, I. and Aisaka, K. (1993). Effects of gammainterferon on collagen and histamine content in bleomycin- induced lung fibrosis in rats. Lymphokine Cytokine Res., 12, 87-91 |
30 | Seagrave, J., Campen, M.J., McDonald, J.D., Mauderly, J.L. and Rohr, A.C. (2008). Oxidative stress, inflammation, and pulmonary function assessment in rats exposed to laboratory-generated pollutant mixtures. J. Toxicol. Environ. Health A, 71, 1352-1362 DOI ScienceOn |
31 | Lynch, J.P., 3rd, White, E. and Flaherty, K. (2001). Corticosteroids in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med., 7, 298-308 DOI |
32 | Tzurel, A., Segel, M.J., Or, R., Goldstein, R.H. and Breuer, R. (2002). Halofuginone does not reduce fibrosis in bleomycin- induced lung injury. Life Sci., 71, 1599-1606 DOI ScienceOn |
33 | El Maghraoui, A., Chaouir, S., Abid, A., Bezza, A., Tabache, F., Achemlal, L., Abouzahir, A., Ghafir, D., Ohayon, V. and Archane, M.I. (2004). Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin. Rheumatol., 23, 123-128 DOI |
34 | Szapiel, S.V., Elson, N.A., Fulmer, J.D., Hunninghake, G.W. and Crystal, R.G. (1979). Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis., 120, 893-899 |
35 | Flaherty, K.R. and Martinez, F.J. (2000). The role of pulmonary function testing in pulmonary fibrosis. Curr. Opin. Pulm. Med., 6, 404-410 DOI ScienceOn |
36 | Lopez-Majano, V. and Renzi, G. (1978). Indications for pulmonary function testing. Respiration, 35, 53-63 DOI |